D-dimer for Patients on VKA Vs DOAC: Impact on the Validity of D-dimer to Make Decision for Extended Anticoagulation

Overview

Journal Blood Adv

Specialty Hematology

Date 2024 May 13

PMID 38739708

Authors

Armando Tripodi

Marco Capecchi

Erica Scalambrino

Marigrazia Clerici

Barbara Scimeca

Pasquale Agosti

Paolo Bucciarelli

Flora Peyvandi

Affiliations

Soon will be listed here.

Citing Articles

Assessment of Hypercoagulability in Splanchnic Vein Thrombosis by Measurement of the Hemostasis Enzymes Thrombin and Activated Protein C.

Reda S, Chang J, Busse J, Schwarz N, McRae H, Muller J Int J Mol Sci. 2025; 26(1.

PMID: 39796151 PMC: 11719462. DOI: 10.3390/ijms26010292.

References

Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A . D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006; 355(17):1780-9. DOI: 10.1056/NEJMoa054444. View

Verhovsek M, Douketis J, Yi Q, Shrivastava S, Tait R, Baglin T . Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008; 149(7):481-90, W94. DOI: 10.7326/0003-4819-149-7-200810070-00008. View

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S . Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med. 2010; 153(8):523-31. DOI: 10.7326/0003-4819-153-8-201010190-00009. View

Reda S, Thiele Serra E, Muller J, Hamedani N, Oldenburg J, Potzsch B . Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study. Front Cardiovasc Med. 2022; 9:830010. PMC: 9008253. DOI: 10.3389/fcvm.2022.830010. View

Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S . Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost. 2002; 87(1):7-12. View

Palareti G, Legnani C, Poli D, Ageno W, Pengo V, Testa S . COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study. Haematologica. 2022; 108(3):923-925. PMC: 9973493. DOI: 10.3324/haematol.2022.282130. View

Kearon C, Parpia S, Spencer F, Schulman S, Stevens S, Shah V . Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study. J Thromb Haemost. 2019; 17(7):1144-1152. DOI: 10.1111/jth.14458. View

Pfeilschifter W, Lindhoff-Last E, Alhashim A, Zydek B, Lindau S, Konstantinides S . Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry. Neurol Res Pract. 2022; 4(1):16. PMC: 9059415. DOI: 10.1186/s42466-022-00183-y. View

Dzudovic J, Dzudovic B, Subota V, Antunovic M, Stavric M, Subotic B . Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients. J Clin Pharm Ther. 2018; 44(2):236-242. DOI: 10.1111/jcpt.12776. View

10.

Cushman M, Folsom A, Wang L, Aleksic N, Rosamond W, Tracy R . Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2002; 101(4):1243-8. DOI: 10.1182/blood-2002-05-1416. View

11.

Palareti G, Poli D, Ageno W, Legnani C, Antonucci E, Bucherini E . D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood Adv. 2022; 6(23):6005-6015. PMC: 9691910. DOI: 10.1182/bloodadvances.2022007973. View

12.

Park J, Hoon Koo D, Yoon D, Lee J . D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs. Ann Vasc Surg. 2016; 34:119-34. DOI: 10.1016/j.avsg.2015.11.038. View

13.

Legnani C, Martinelli I, Palareti G, Ciavarella A, Poli D, Ageno W . D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants. PLoS One. 2019; 14(7):e0219751. PMC: 6634858. DOI: 10.1371/journal.pone.0219751. View